Scala C, Leone Roberti Maggiore U, Barra F, Tantari M, Ferrero S. Impact of Endometriomas and Deep Infiltrating Endometriosis on Pregnancy Outcomes and on First and Second Trimester Markers of Impaired Placentation. Medicina (Kaunas);55(9). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780829/
Preoperative Hormonal Treatment Before Laparoscopic Approach for Uterine Fibroids: Do We Need It?
Barra F, Evangelisti G, Ferrero S. Preoperative Hormonal Treatment Before Laparoscopic Approach for Uterine Fibroids: Do We Need It? J Invest Surg. 2019 Aug 28:1-3. https://www.tandfonline.com/doi/full/10.1080/08941939.2019.1655118
Mucinous ovarian cancer: current therapeutic targets, preclinical progress, and experimental drugs
Moioli M, Barra F, Maramai M, Valenzano Menada M, Vellone VG, Costantini S, Ferrero S. Mucinous ovarian cancer: current therapeutic targets, preclinical progress, and experimental drugs. Expert Opin Investig Drugs 2019;28:1025-1029. https://www.tandfonline.com/doi/abs/10.1080/13543784.2019.1693999?journalCode=ieid20
Application of failure mode and effect analysis in total laparoscopic hysterectomy in benign conditions
Lijoi D, Farina M, Puppo A, Novelli A, Ferrero S. Application of failure mode and effect analysis in total laparoscopic hysterectomy in benign conditions. Minerva Ginecol. 2019 Aug;71(4):272-280. https://www.minervamedica.it/it/riviste/minerva-ginecologica/articolo.php?cod=R09Y2019N04A0272
Relugolix for the treatment of uterine fibroids
Barra F, Seca M, Della Corte L, Giampaolino P, Ferrero S. Relugolix for the treatment of uterine fibroids. Drugs Today (Barc) 2019;55:503-512. https://journals.prous.com/journals/servlet/xmlxsl/pk_journals.xml_summaryn_pr?p_JournalId=4&p_RefId=3020179